Extracellular matrix structure AD Theocharis, SS Skandalis, C Gialeli, NK Karamanos Advanced drug delivery reviews 97, 4-27, 2016 | 2334 | 2016 |
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting C Gialeli, AD Theocharis, NK Karamanos The FEBS journal 278 (1), 16-27, 2011 | 1878 | 2011 |
Glycosaminoglycans: key players in cancer cell biology and treatment N Afratis, C Gialeli, D Nikitovic, T Tsegenidis, E Karousou, AD Theocharis, ... The FEBS journal 279 (7), 1177-1197, 2012 | 609 | 2012 |
Hyaluronan–CD44 interactions as potential targets for cancer therapy S Misra, P Heldin, VC Hascall, NK Karamanos, SS Skandalis, ... The FEBS journal 278 (9), 1429-1443, 2011 | 550 | 2011 |
A guide to the composition and functions of the extracellular matrix NK Karamanos, AD Theocharis, Z Piperigkou, D Manou, A Passi, ... The FEBS journal 288 (24), 6850-6912, 2021 | 497 | 2021 |
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting AD Theocharis, SS Skandalis, GN Tzanakakis, NK Karamanos The FEBS journal 277 (19), 3904-3923, 2010 | 478 | 2010 |
The extracellular matrix as a multitasking player in disease AD Theocharis, D Manou, NK Karamanos The FEBS journal 286 (15), 2830-2869, 2019 | 401 | 2019 |
Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer AG Tavianatou, I Caon, M Franchi, Z Piperigkou, D Galesso, ... The FEBS journal 286 (15), 2883-2908, 2019 | 332 | 2019 |
Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics NK Karamanos, Z Piperigkou, AD Theocharis, H Watanabe, M Franchi, ... Chemical reviews 118 (18), 9152-9232, 2018 | 308 | 2018 |
Derivatization of carbohydrates for chromatographic, electrophoretic and mass spectrometric structure analysis FN Lamari, R Kuhn, NK Karamanos Journal of Chromatography B 793 (1), 15-36, 2003 | 299 | 2003 |
Syndecans–key regulators of cell signaling and biological functions NA Afratis, D Nikitovic, HAB Multhaupt, AD Theocharis, JR Couchman, ... The FEBS journal 284 (1), 27-41, 2017 | 272 | 2017 |
Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans SS Skandalis, N Afratis, G Smirlaki, D Nikitovic, AD Theocharis, ... Matrix Biology 35, 182-193, 2014 | 248 | 2014 |
Matrix modeling and remodeling: a biological interplay regulating tissue homeostasis and diseases NK Karamanos, AD Theocharis, T Neill, RV Iozzo Matrix Biology 75, 1-11, 2019 | 221 | 2019 |
Inhaled chemotherapy in lung cancer: future concept of nanomedicine P Zarogoulidis, E Chatzaki, K Porpodis, K Domvri, W Hohenforst-Schmidt, ... International journal of nanomedicine, 1551-1572, 2012 | 211 | 2012 |
Inhibition of breast cancer cell proliferation by style constituents of different Crocus species DG Chryssanthi, FN Lamari, G Iatrou, A Pylara, NK Karamanos, ... Anticancer research 27 (1A), 357-362, 2007 | 210 | 2007 |
Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer E Karousou, S Misra, S Ghatak, K Dobra, M Götte, D Vigetti, A Passi, ... Matrix Biology 59, 3-22, 2017 | 201 | 2017 |
Proteoglycans remodeling in cancer: Underlying molecular mechanisms AD Theocharis, NK Karamanos Matrix Biology 75, 220-259, 2019 | 199 | 2019 |
Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells P Bouris, SS Skandalis, Z Piperigkou, N Afratis, K Karamanou, AJ Aletras, ... Matrix Biology 43, 42-60, 2015 | 193 | 2015 |
Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease C Malavaki, S Mizumoto, N Karamanos, K Sugahara Connective tissue research 49 (3-4), 133-139, 2008 | 191 | 2008 |
Lumican, a small leucine‐rich proteoglycan D Nikitovic, P Katonis, A Tsatsakis, NK Karamanos, GN Tzanakakis IUBMB life 60 (12), 818-823, 2008 | 166 | 2008 |